[HTML][HTML] Liver X receptor-mediated activation of reverse cholesterol transport from macrophages to feces in vivo requires ABCG5/G8
L Calpe-Berdiel, N Rotllan, C Fiévet, R Roig… - Journal of lipid …, 2008 - ASBMB
Liver X receptor (LXR) agonists increase both total fecal sterol excretion and macrophage-
specific reverse cholesterol transport (RCT) in vivo. In this study, we assessed the effects of …
specific reverse cholesterol transport (RCT) in vivo. In this study, we assessed the effects of …
[PDF][PDF] Liver X receptor-mediated activation of reverse cholesterol transport from macrophages to feces in vivo requires ABCG5/G8
L Calpe-Berdiel, N Rotllan, C Fiévet, R Roig… - 2008 - academia.edu
Liver X receptor (LXR) agonists increase both total fecal sterol excretion and macrophage-
specific reverse cholesterol transport (RCT) in vivo. In this study, we assessed the effects of …
specific reverse cholesterol transport (RCT) in vivo. In this study, we assessed the effects of …
Liver X receptor-mediated activation of reverse cholesterol transport from macrophages to feces in vivo requires ABCG5/G8
L Calpe-Berdiel, N Rotllan, C Fiévet, R Roig… - Journal of Lipid …, 2008 - hero.epa.gov
Liver X receptor (LXR) agonists increase both total fecal sterol excretion and macrophage-
specific reverse cholesterol transport (RCT) in vivo. In this study, we assessed the effects of …
specific reverse cholesterol transport (RCT) in vivo. In this study, we assessed the effects of …
Liver X receptor-mediated activation of reverse cholesterol transport from macrophages to feces in vivo requires ABCG5/G8
L Calpe-Berdiel, N Rotllan, C Fiévet… - Journal of lipid …, 2008 - pubmed.ncbi.nlm.nih.gov
Liver X receptor (LXR) agonists increase both total fecal sterol excretion and macrophage-
specific reverse cholesterol transport (RCT) in vivo. In this study, we assessed the effects of …
specific reverse cholesterol transport (RCT) in vivo. In this study, we assessed the effects of …
[HTML][HTML] Liver X receptor-mediated activation of reverse cholesterol transport from macrophages to feces in vivo requires ABCG5/G8
L Calpe-Berdiel, N Rotllan, C Fiévet, R Roig… - Journal of Lipid …, 2008 - Elsevier
Liver X receptor (LXR) agonists increase both total fecal sterol excretion and macrophage-
specific reverse cholesterol transport (RCT) in vivo. In this study, we assessed the effects of …
specific reverse cholesterol transport (RCT) in vivo. In this study, we assessed the effects of …
Liver X receptor-mediated activation of reverse cholesterol transport from macrophages to feces in vivo requires ABCG5/G8
L Calpe-Berdiel, N Rotllan, C Fiévet… - Journal of Lipid …, 2008 - portalrecerca.uab.cat
Liver X receptor (LXR) agonists increase both total fecal sterol excretion and macrophage-
specific reverse cholesterol transport (RCT) in vivo. In this study, we assessed the effects of …
specific reverse cholesterol transport (RCT) in vivo. In this study, we assessed the effects of …
Liver X receptor-mediated activation of reverse cholesterol transport from macrophages to feces in vivo requires ABCG5/G8.
L Calpe-Berdiel, N Rotllan, C Fiévet, R Roig… - Journal of Lipid …, 2008 - europepmc.org
Liver X receptor (LXR) agonists increase both total fecal sterol excretion and macrophage-
specific reverse cholesterol transport (RCT) in vivo. In this study, we assessed the effects of …
specific reverse cholesterol transport (RCT) in vivo. In this study, we assessed the effects of …
[PDF][PDF] Liver X receptor-mediated activation of reverse cholesterol transport from macrophages to feces in vivo requires ABCG5/G8
L Calpe-Berdiel, N Rotllan, C Fiévet, R Roig… - 2008 - researchgate.net
Liver X receptor (LXR) agonists increase both total fecal sterol excretion and macrophage-
specific reverse cholesterol transport (RCT) in vivo. In this study, we assessed the effects of …
specific reverse cholesterol transport (RCT) in vivo. In this study, we assessed the effects of …